Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes

The 2019 European Society of Cardiology guidelines for the management of dyslipidemia consider the use of high-dose marine omega-3 fatty acid (FA) eicosapentaenoic acid (EPA) supplementation (icosapent ethyl 2 × 2g/day) to lower residual cardiovascular risk in high-risk patients with hypertriglyceri...

Full description

Bibliographic Details

Published in:	Atherosclerosis plus Vol. 58; pp. 1 - 8
Main Authors:	Follonier, Cédric, Rabassa, Gabriel, Branca, Mattia, Carballo, David, Koskinas, Konstantinos, Heg, Dik, Nanchen, David, Räber, Lorenz, Klingenberg, Roland, Haller, Moa Lina, Carballo, Sebastian, Windecker, Stephan, Matter, Christian M., Rodondi, Nicolas, Mach, François, Gencer, Baris
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.12.2024 Elsevier
Subjects:	Acute coronary syndrome Dyslipidemia Full Length Heart disease risk factor Hypertriglyceridemia Omega-3 fatty acids Secondary prevention Secondary prevention Acute coronary syndrome Hypertriglyceridemia Omega-3 fatty acids Dyslipidemia Heart disease risk factor
ISSN:	2667-0895, 2667-0909, 2667-0895
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!